Home LiteratureArticle Details
PMID: 15085195 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs.

The Journal of clinical investigation ·Vol. 113 ·No. 8 ·2004-04-00 ·Pages 1158-67

Sitia G, Isogawa M, Iannacone M, Campbell IL, Chisari FV, Guidotti LG

Abstract

We recently showed that antigen-nonspecific inflammatory cells are recruited into the liver when hepatitis B virus (HBV)-specific CTLs are injected into HBV transgenic mice, and that this process amplifies the severity of liver disease. We also showed that the severity of CTL-induced liver disease is ameliorated by the depletion of Gr-1(+) cells (Gr-1 is an antigen highly expressed by neutrophils), which, secondarily, abolishes the intrahepatic recruitment of all antigen-nonspecific Gr-1(-) mononuclear cells (NK and NKT cells, T and B lymphocytes, monocytes, macrophages, dendritic cells) despite the strong induction of chemokine gene expression. Those results suggested that in addition to chemokine expression, CTL-induced functions are necessary for mononuclear cell recruitment to occur. We now report that MMPs known to be produced by Gr-1(+) cells are rapidly induced in the livers of CTL-injected mice. The inhibition of MMP activity reduced the intrahepatic recruitment of antigen-nonspecific mononuclear cells and much of the attending liver disease without affecting the migration or antiviral potential of antigen-specific CTLs. The notion that the inhibition of MMP activity is associated with maintenance of antiviral effects but diminished tissue damage may be significant for the development of immunotherapeutic approaches for the treatment of chronic HBV infection.

MeSH Terms
Animals Cell Movement Collagenases/biosynthesis Female Gelatinases/biosynthesis Hepatitis B virus/immunology Hepatitis B, Chronic/immunology,therapy Leukocytes, Mononuclear/immunology Liver/pathology Male Matrix Metalloproteinase 8/physiology Matrix Metalloproteinase 9/physiology Matrix Metalloproteinases/physiology Mice Mice, Inbred C57BL Mice, Transgenic T-Lymphocytes, Cytotoxic/immunology Tissue Inhibitor of Metalloproteinase-1/physiology
Chemicals
Tissue Inhibitor of Metalloproteinase-1 Collagenases Gelatinases Matrix Metalloproteinases Matrix Metalloproteinase 8 Matrix Metalloproteinase 9
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Sitia Giovanni
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.
Isogawa Masanori
Iannacone Matteo
Campbell Iain L
Chisari Francis V
Guidotti Luca G
References (38)
38 references, click to expand
  1. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.
    J Virol. 2000 Mar;74(5):2255-64 PMID: 10666256
  2. RNAse protection assays for the simultaneous and semiquantitative analysis of multiple murine matrix metalloproteinase (MMP) and MMP inhibitor mRNAs.
    J Immunol Methods. 1997 Aug 7;206(1-2):1-9 PMID: 9328562
  3. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.
    J Exp Med. 2000 Apr 17;191(8):1269-80 PMID: 10770795
  4. The biology of chemokines and their receptors.
    Annu Rev Immunol. 2000;18:217-42 PMID: 10837058
  5. Regulation of liver inflammatory injury by signal transducer and activator of transcription-6.
    Am J Pathol. 2000 Jul;157(1):297-302 PMID: 10880399
  6. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia.
    J Cereb Blood Flow Metab. 1999 Jun;19(6):624-33 PMID: 10366192
  7. Experimental metastasis is suppressed in MMP-9-deficient mice.
    Clin Exp Metastasis. 1999 Mar;17(2):177-81 PMID: 10411111
  8. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes.
    J Neurosci. 1999 Oct 1;19(19):8464-75 PMID: 10493747
  9. Gelatinase B functions as regulator and effector in leukocyte biology.
    J Leukoc Biol. 2001 Jun;69(6):851-9 PMID: 11404367
  10. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells.
    J Exp Med. 2001 Oct 15;194(8):1171-8 PMID: 11602645
  11. How matrix metalloproteinases regulate cell behavior.
    Annu Rev Cell Dev Biol. 2001;17:463-516 PMID: 11687497
  12. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.
    Nat Med. 2001 Nov;7(11):1202-8 PMID: 11689884
  13. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.
    J Exp Med. 2001 Dec 17;194(12):1755-66 PMID: 11748277
  14. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.
    Nature. 2002 Jul 11;418(6894):191-5 PMID: 12110890
  15. Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation.
    Am J Pathol. 2002 Aug;161(2):491-8 PMID: 12163374
  16. Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections.
    J Virol. 2002 Sep;76(17):8609-20 PMID: 12163580
  17. Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
    J Cell Sci. 2002 Oct 1;115(Pt 19):3719-27 PMID: 12235282
  18. The mononuclear phagocyte system revisited.
    J Leukoc Biol. 2002 Oct;72(4):621-7 PMID: 12377929
  19. Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes.
    Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13717-22 PMID: 12368481
  20. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection.
    Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13825-30 PMID: 12374864
  21. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus.
    J Clin Invest. 2002 Oct;110(8):1105-11 PMID: 12393846
  22. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta.
    J Exp Med. 2003 Apr 7;197(7):885-98 PMID: 12682109
  23. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities.
    Eur J Biochem. 2003 Sep;270(18):3739-49 PMID: 12950257
  24. Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase.
    Biochem Biophys Res Commun. 2003 Oct 24;310(3):889-96 PMID: 14550288
  25. A novel population of Gr-1+-activated macrophages induced during acute toxoplasmosis.
    J Leukoc Biol. 2003 Dec;74(6):1015-25 PMID: 12972511
  26. Light microscopic morphology of viral hepatitis.
    Am J Clin Pathol. 1976 May;65(5 Suppl):787-827 PMID: 802746
  27. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.
    J Exp Med. 1993 Nov 1;178(5):1541-54 PMID: 8228807
  28. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?
    Curr Opin Immunol. 2000 Aug;12(4):403-8 PMID: 10899021
  29. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.
    Blood. 2000 Dec 1;96(12):3838-46 PMID: 11090068
  30. Matrix metalloproteinases in tumor invasion and metastasis.
    Semin Cancer Biol. 2000 Dec;10(6):415-33 PMID: 11170864
  31. Noncytolytic control of viral infections by the innate and adaptive immune response.
    Annu Rev Immunol. 2001;19:65-91 PMID: 11244031
  32. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo.
    J Immunol. 1994 Apr 1;152(7):3245-53 PMID: 8144915
  33. Hepatitis B virus immunopathogenesis.
    Annu Rev Immunol. 1995;13:29-60 PMID: 7612225
  34. High-level hepatitis B virus replication in transgenic mice.
    J Virol. 1995 Oct;69(10):6158-69 PMID: 7666518
  35. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.
    Immunity. 1996 Jan;4(1):25-36 PMID: 8574849
  36. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver.
    Proc Natl Acad Sci U S A. 1996 May 14;93(10):4589-94 PMID: 8643448
  37. Flow cytometric identification of murine neutrophils and monocytes.
    J Immunol Methods. 1996 Oct 16;197(1-2):139-50 PMID: 8890901
  38. Chemokines: a new classification system and their role in immunity.
    Immunity. 2000 Feb;12(2):121-7 PMID: 10714678
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
2004-04-00
Pages
1158-67
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC385409
Subset
IM
Grants
NCI NIH HHS · R37 CA040489 · United States
NCI NIH HHS · CA40489 · United States
NINDS NIH HHS · NS36979 · United States
NINDS NIH HHS · R01 NS036979 · United States
NCI NIH HHS · R01 CA040489 · United States
NIAID NIH HHS · R01 AI040696 · United States
NIAID NIH HHS · AI40696 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]